Stocks and Investing Stocks and Investing
Mon, October 14, 2019
[ 12:00 AM ] - United States, WOPRAI
Christopher Turnure Maintained (AEP) at Buy with Increased Target to $104 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Philip Gibbs Maintained (USAP) at Buy with Decreased Target to $20 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Decreased Target to $90 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Zachary Fadem Maintained (TSCO) at Buy with Decreased Target to $115 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Carrier Upgraded (VRTS) to Strong Buy on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Maintained (SNA) at Hold with Increased Target to $165 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Ananda Baruah Upgraded (WDC) to Strong Buy on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Nick Setyan Maintained (WEN) at Hold with Increased Target to $22 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
John Glass Maintained (WEN) at Hold with Increased Target to $22 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Philip Gibbs Maintained (ATI) at Buy with Decreased Target to $28 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Chris Shaw Upgraded (ASH) to Strong Buy and Held Target at $88 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Mitch Steves Maintained (ASML) at Buy with Increased Target to $270 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Drew Babin Upgraded (UDR) to Buy on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Christopher Turnure Maintained (SRE) at Hold with Increased Target to $74 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Jay Sole Downgraded (TPR) to Hold and Held Target at $25 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Andrew Schmitt Maintained (WU) at Strong Sell with Increased Target to $21 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Jayson Bedford Maintained (BSX) at Strong Buy with Decreased Target to $48 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Carrier Downgraded (BX) to Hold on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Charles Peters Maintained (BRO) at Buy with Increased Target to $39 on, Oct 14th, 2019
[ 12:00 AM ] - United States, WOPRAI
Richard Sunderland Maintained (CMS) at Buy with Decreased Target to $71 on, Oct 14th, 2019
Fri, October 11, 2019
[ 12:00 AM ] - United States, WOPRAI
Gary Mobley Upgraded (CDNS) to Buy and Increased Target to $80 on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Adam Seiden Downgraded (TEX) to Sell on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Tristan Van Strien Downgraded (TAP) to Strong Sell on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $109 on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Jon Windham Maintained (TPIC) at Strong Buy with Decreased Target to $27 on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Adam Graf Maintained (SSRM) at Hold with Decreased Target to $17 on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (SRPT) at Buy with Decreased Target to $160 on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
James Friedman Upgraded (SQ) to Buy on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
Dan Dolev Initiated (SQ) at Sell and Held Target at $49 on, Oct 11th, 2019
[ 12:00 AM ] - United States, WOPRAI
David Lebovitz Initiated (ASND) at Buy and Held Target at $128 on, Oct 11th, 2019

David Lebovitz Initiated (ASND) at Buy and Held Target at $128 on, Oct 11th, 2019


Published on 2024-10-26 16:52:10 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Initiated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $128 on, Oct 11th, 2019.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019

Contributing Sources